• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session

    12/1/22 1:33:38 PM ET
    $AHI
    $AIMD
    $ARCE
    $AURA
    Package Goods/Cosmetics
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHI alert in real time by email

    Gainers

    • Top Ships Inc. (NASDAQ:TOPS) shares jumped 74% to $5.24.
    • Vapotherm, Inc. (NASDAQ:VAPO) gained 48.8% to $1.3250.
    • The Alkaline Water Company Inc. (NASDAQ:WTER) gained 37.5% to $0.24.
    • Wearable Devices Ltd. (NASDAQ:WLDS) jumped 30.8% to $0.8551.
    • Vaxxinity, Inc. (NASDAQ:VAXX) gained 27% to $3.33. Vaxxinity recently posted a Q3 loss of $0.15 per share.
    • Pacifico Acquisition Corp. (NASDAQ:PAFO) shares rose 26.9% to $6.83 after dipping around 43% on Wednesday.
    • Advanced Human Imaging Limited (NASDAQ:AHI) gained 26.8% to $0.5201.
    • Arco Platform Limited (NASDAQ:ARCE) shares climbed 21.6% to $10.99 after the company announced receipt of a non-binding going private proposal.
    • Core Scientific, Inc. (NASDAQ:CORZ) jumped 21% to $0.1614.
    • Okta, Inc. (NASDAQ:OKTA) gained 20.6% to $64.30 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
    • Sonim Technologies, Inc. (NASDAQ:SONM) jumped 20% to $0.4911 after the company announced a $17 million additional tablet order.
    • Oncolytics Biotech Inc. (NASDAQ:ONCY) rose 20.2% to $2.11. Oncolytics Biotech received FDA fast track designation for the treatment of advanced/metastatic pancreatic cancer.
    • Ainos, Inc. (NASDAQ:AIMD) gained 19.8% to $0.72.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) jumped 19.2% to $7.99. Kintara Therapeutics recently regained compliance with Nasdaq minimum bid price requirement.
    • COMSovereign Holding Corp. (NASDAQ:COMS) surged 19% to $0.1085 after the company received approval for continued listing on The Nasdaq Capital Market.
    • Yext, Inc. (NYSE:YEXT) gained 18.3% to $6.30 after the company reported better-than-expected Q3 adjusted EPS results and issued Q4 adjusted EPS guidance above estimates.
    • Five Below, Inc. (NASDAQ:FIVE) surged 16.3% to $187.09 after the company reported better-than-expected Q3 results and issued FY22 guidance above estimates.
    • Ra Medical Systems, Inc. (NYSE:RMED) rose 16.1% to $2.8450 after jumping 16% on Wednesday. Ra Medical recently posted a Q3 loss of $4.36 per share.
    • REX American Resources Corporation (NYSE:REX) climbed 16% to $34.24 after the company reported better-than-expected Q3 EPS and sales results.
    • Mullen Automotive, Inc. (NASDAQ:MULN) gained 15% to $0.2213 after the company announced it closed on the acquisition of Electric Last Mile Solutions' assets.
    • SelectQuote, Inc. (NYSE:SLQT) gained 14.3% to $0.6860. SelectQuote recently posted a Q1 loss of $0.26 per share.
    • Avaya Holdings Corp. (NASDAQ:AVYA) rose 13.7% to $1.1004.
    • GoodRx Holdings, Inc. (NASDAQ:GDRX) gained 13.5% to $4.9519 after Citigroup initiated coverage on the stock with a Buy rating and announced a $7 price target.
    • electroCore, Inc. (NASDAQ:ECOR) jumped 12.9% to $0.3740.
    • Kidpik Corp. (NASDAQ:PIK) gained 12.6% to $0.8627.
    • Splunk Inc. (NASDAQ:SPLK) rose 12% to $87.01 after the company reported better-than-expected results for its third quarter and raised FY23 sales guidance.
    • Bausch Health Companies Inc. (NYSE:BHC) gained 10% to $7.74.
    • MMTec, Inc. (NASDAQ:MTC) gained 9.2% to $1.19.
    • PVH Corp. (NYSE:PVH) gained 8.1% to $72.63 following Q3 results.


    Losers

    • G-III Apparel Group, Ltd. (NASDAQ:GIII) shares fell 42.7% to $12.39 after the company reported worse-than-expected Q3 earnings and issued weak FY23 adjusted EPS guidance.
    • Aziyo Biologics, Inc. (NASDAQ:AZYO) dipped 39.9% to $4.1499 after the company announced pricing of an $11.2 million public offering of common stock.
    • Yunhong CTI Ltd. (NASDAQ:CTIB) fell 36.5% to $0.5498. Yunhong CTI recently posted a Q3 loss of $0.12 per share.
    • Winc, Inc. (NYSE:WBEV) fell 26.6% to $0.2175. Winc recently posted a Q3 loss of $0.33 per share.
    • Lands' End, Inc. (NASDAQ:LE) fell 26.5% to $8.50 after the company reported worse-than-expected Q3 adjusted EPS and sales results and cut FY22 net revenue guidance.
    • SQZ Biotechnologies Company (NYSE:SQZ) fell 26.1% to $1.8550 after the company announced a strategic repriortization of its portfolio, CEO Armon Sharei will step down and a workforce reduction of approximately 60%. Also, B of A Securities downgraded the stock from Buy to Underpeform and lowered its price target from $9 to $2.
    • Biodesix, Inc. (NASDAQ:BDSX) shares fell 24.5% to $1.51 after surging 47% on Wednesday.
    • Designer Brands Inc. (NYSE:DBI) dipped 21.6% to $11.98 after the company reported worse-than-expected Q3 adjusted EPS and sales results and lowered FY22 EPS guidance below estimates.
    • Farfetch Limited (NASDAQ:FTCH) dropped 21.5% to $6.67 after the company issued FY23 and FY25 guidance.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) fell 21.5% to $0.1526 after jumping 60% on Wednesday.
    • Reed's, Inc. (NASDAQ:REED) fell 19.5% to $0.1030. Reed's recently lowered FY22 revenue outlook.
    • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) dropped 19% to $0.1101 after the company announced a 1-for-40 reverse stock split.
    • Satixfy Communications Ltd. (NYSE:SATX) fell 18.3% to $18.70.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) fell 18.3% to $4.11.
    • Duluth Holdings Inc. (NASDAQ:DLTH) dipped 17.8% to $7.20 after the company posted downbeat quarterly earnings and lowered FY22 guidance.
    • Biophytis S.A. (NASDAQ:BPTS) fell 17.8% to $0.55.
    • Aura Biosciences, Inc. (NASDAQ:AURA) declined 16.6% to $11.91 after the company announced pricing of a public offering of common stock.
    • Genius Group Limited (NYSE:GNS) dropped 16.3% to $0.4603.
    • Tuesday Morning Corporation (NASDAQ:TUEM) fell 14.1% to $2.9955.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) shares fell 12.5% to $3.07 after jumping over 41% on Wednesday.
    • Big Lots, Inc. (NYSE:BIG) dropped 11.6% to $17.24 after the company reported worse-than-expected Q3 adjusted EPS and sales results.
    • FREYR Battery (NYSE:FREY) fell 10.7% to $12.19 after the company announcing pricing of an upsized $230 million public offering.
    • Salesforce, Inc. (NYSE:CRM) shares fell 9.9% to $144.44 after the company reported third-quarter results and announced that Bret Taylor will step down as vice chair and co-CEO.
    • Caleres, Inc. (NYSE:CAL) fell 8.9% to $22.01.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares fell 8.7% to $0.1201 after declining over 7% on Wednesday. Panbela recentlys said first patients enrolled in Europe for ASPIRE trial studying Ivospemin (SBP-101) in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
    • Dollar General Corporation (NYSE:DG) fell 8.5% to $233.91 after the company reported worse-than-expected Q3 EPS results and issued Q4 EPS guidance below estimates.
    • Genesco Inc. (NYSE:GCO) fell 7.1% to $48.51.
    • Elastic N.V. (NYSE:ESTC) fell 6.9% to $56.99 after the company posted upbeat Q2 results and issued strong earnings forecast.
    • Costco Wholesale Corporation (NASDAQ:COST) dropped 6.7% to $503.32 after the company reported November sales results.
    • XPeng Inc. (NYSE:XPEV) fell 6.1% to $10.15. XPeng shares jumped over 47% on Wednesday after reporting quarterly results.
    • Credit Suisse Group AG (NYSE:CS) fell 5.6% to $3.0950. The company recently said it expects to post a loss for the quarter. Shareholders last week also approved the company's capital raise plan.
    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $AIMD
    $ARCE
    $AURA

    CompanyDatePrice TargetRatingAnalyst
    Salesforce Inc.
    $CRM
    2/20/2026$275.00 → $235.00Outperform
    BMO Capital Markets
    Dollar General Corporation
    $DG
    2/17/2026$111.00Neutral → Sell
    Rothschild & Co Redburn
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    GoodRx Holdings Inc.
    $GDRX
    1/22/2026$2.75Buy → Hold
    Jefferies
    PVH Corp.
    $PVH
    1/14/2026$85.00Buy
    Jefferies
    Okta Inc.
    $OKTA
    1/14/2026$120.00Equal-Weight → Overweight
    Stephens
    Five Below Inc.
    $FIVE
    1/13/2026$210.00Buy → Hold
    Jefferies
    Five Below Inc.
    $FIVE
    1/13/2026$195.00 → $240.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $AHI
    $AIMD
    $ARCE
    $AURA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yext to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on March 9, 2026

    Yext, Inc. (NYSE:YEXT), the leading digital presence platform for multi-location brands, today announced that its fourth quarter and full fiscal year 2026 results will be released on Monday, March 9, 2026, after the close of the market. About Yext Yext is the leading digital presence platform for multi-location brands, with thousands of customers worldwide. With one central platform, brands can seamlessly deliver consistent, accurate, and engaging experiences and meaningfully connect with customers anywhere in the digital world. Yext's AI and machine learning technology powers the knowledge behind every customer engagement, automates workflows at scale, and delivers actionable cross-chann

    2/23/26 4:05:00 PM ET
    $YEXT
    EDP Services
    Technology

    Yext Has Chosen to Strategically Partner with AdCellerant to Help Organizations Manage and Optimize Brand Visibility

    DENVER, Feb. 23, 2026 /PRNewswire/ -- AdCellerant, a leading digital advertising technology and services company, announced today a new partnership with Yext, the leading brand visibility platform. AdCellerant will partner with Yext to deliver this enhanced service model, reflecting a shared commitment to operational excellence and long-term customer success. Yext has chosen to strategically partner with AdCellerant to help organizations manage and optimize brand visibility.The partnership brings together Yext's industry-leading platform with AdCellerant's hands-on expertise and

    2/23/26 12:06:00 PM ET
    $YEXT
    EDP Services
    Technology

    Elastic Introduces Best-in-Class Embedding Models for High Performance Semantic Search

    New Jina AI small language models deliver unmatched quality and efficiency on search and semantic tasks Elastic (NYSE:ESTC), the Search AI Company, today announced the availability of jina-embeddings-v5-text, a family of two small, Elasticsearch-native multilingual embedding models at 0.2B and 0.6B parameters that deliver state-of-the-art performance across key search and semantic tasks. Despite their compact size, they outperform significantly larger models with 7B to 14B parameters and achieve best-in-class results on the MMTEB (Multilingual MTEB) benchmark among models of comparable size and purpose. Their small footprint enables outstanding hybrid search at lower infrastructure cost

    2/23/26 12:00:00 PM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    $AHI
    $AIMD
    $ARCE
    $AURA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Salesforce with a new price target

    BMO Capital Markets reiterated coverage of Salesforce with a rating of Outperform and set a new price target of $235.00 from $275.00 previously

    2/20/26 7:54:01 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Dollar General downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Dollar General from Neutral to Sell and set a new price target of $111.00

    2/17/26 8:12:52 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Five Below upgraded by BofA Securities with a new price target

    BofA Securities upgraded Five Below from Underperform to Buy and set a new price target of $233.00

    2/4/26 8:24:40 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AHI
    $AIMD
    $ARCE
    $AURA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Director Pisano Wayne bought $25,338 worth of shares (30,000 units at $0.84), increasing direct ownership by 6% to 492,414 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:29 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Kelly Jared bought $29,521 worth of shares (35,100 units at $0.84), increasing direct ownership by 47% to 109,000 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:32 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $AIMD
    $ARCE
    $AURA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Vazquez Chris sold $2,696 worth of shares (211 units at $12.78) and converted options into 563 shares, increasing direct ownership by 29% to 1,586 units (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    2/23/26 8:22:21 PM ET
    $BDSX
    Medical Specialities
    Health Care

    CFO, Sec'y & Treasurer Cowie Robin Harper converted options into 1,469 shares and sold $6,835 worth of shares (535 units at $12.78), increasing direct ownership by 6% to 16,231 units (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    2/23/26 8:22:23 PM ET
    $BDSX
    Medical Specialities
    Health Care

    Chief Commercial Officer O'Kane Kieran converted options into 1,469 shares and sold $6,835 worth of shares (535 units at $12.78), increasing direct ownership by 11% to 9,819 units (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    2/23/26 8:22:24 PM ET
    $BDSX
    Medical Specialities
    Health Care

    $AHI
    $AIMD
    $ARCE
    $AURA
    SEC Filings

    View All

    Amendment: SEC Form SC TO-I/A filed by Yext Inc.

    SC TO-I/A - Yext, Inc. (0001614178) (Subject)

    2/23/26 4:10:43 PM ET
    $YEXT
    EDP Services
    Technology

    SEC Form 6-K filed by TOP Ships Inc.

    6-K - TOP SHIPS INC. (0001296484) (Filer)

    2/23/26 8:00:22 AM ET
    $TOPS
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.

    SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/19/26 9:17:28 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $AHI
    $AIMD
    $ARCE
    $AURA
    Leadership Updates

    Live Leadership Updates

    View All

    Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer

    Appointment Effective February 16, 2026 COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), today announced that Sheamus Toal will join the company as Executive Vice President, Chief Financial Officer and Principal Financial Officer, effective February 16, 2026. Mark Haley, who has served as Interim Principal Financial Officer during the transition period, will return full time to his position as Senior Vice President, Controller and Principal Accounting Officer. Sheamus brings deep financial

    2/11/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

    VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive $185.69 billion by 2035 as the industry moves toward the coordinated activation of the immune system[1]. This surge is being accelerated by the $69.16 billion genomics revolution, which is now integrating advanced profiling into every oncology workflow to pick winning treatments[2]. This strategic push for registration-ready precision assets fuels the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:ONCY), ImmunityBio (NASDAQ:IBRX), OS Therapies (NYSE-A: OSTX), BioNTech SE (NASDAQ:BNTX),

    1/14/26 10:39:59 AM ET
    $BNTX
    $CMPX
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics

    SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the appointment of John McAdory as Executive Vice President of Strategy and Operations and Yujun Wu as Vice President, Head of Biostatistics. These appointments are expected to enhance the Company's operational, clinical, and regulatory capabilities as Oncolytics advances registration-directed development programs in pancreatic, colorectal, and anal cancers. Mr. McAdory will oversee clinical development execution, operational strategy, and regulatory readiness across the Company's portfolio. He br

    1/14/26 9:00:00 AM ET
    $CGON
    $ONCY
    $TAK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AHI
    $AIMD
    $ARCE
    $AURA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AHI
    $AIMD
    $ARCE
    $AURA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Designer Brands Inc.

    SC 13G/A - Designer Brands Inc. (0001319947) (Subject)

    12/12/24 6:00:14 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    $AHI
    $AIMD
    $ARCE
    $AURA
    Financials

    Live finance-specific insights

    View All

    Core Scientific, Inc. Schedules Fourth Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, today announced it will release its fourth quarter and fiscal year 2025 financial results after the financial markets close on Monday, March 2, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quarter and fiscal year 2025 will be Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webc

    2/23/26 7:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Genesco to Report Fourth Quarter Fiscal 2026 Financial Results and Hold Conference Call on March 6, 2026

    Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the fourth quarter fiscal 2026 on March 6, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the fourth quarter fiscal 2026 results will be available on the Genesco website on March 6, 2026 at https://www.genesco.com/investor-relations/investor-o

    2/18/26 4:30:00 PM ET
    $GCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP)1 basis over the prior year periodFull-Year Consolidated Revenues of $10.27 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basisGAAP Net Loss Attributable to Bausch Health of $112 million for the quarter and GAAP Net Income Attributable to Bausch Health of $157 million for the yearConsolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $1.05 billion for the quarter, up 13%, and $3.54 billion for the year, up 7%BAUSCH HEALTH EXCLUDING BAUSCH + LOMB FOURTH QUARTER AND FULL-YEAR 2025 RESULTSDelivered eleventh consecutive quarter of year-over-y

    2/18/26 4:05:00 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care